Technology in Business
Tillman Gerngross, Adagio Therapeutics CEO, joins ‘The Exchange’ to discuss how his company’s antibody drug was developed and its effectiveness in fighting Covid variants.
Credit CNBC Television
Adagio Therapeutics CEO: We see a role in the treatment of Covid, as well as prevention
